TD Asset Management Inc. Sells 171,467 Shares of Encompass Health Co. (NYSE:EHC)

TD Asset Management Inc. lessened its holdings in shares of Encompass Health Co. (NYSE:EHC) by 10.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,522,909 shares of the company’s stock after selling 171,467 shares during the quarter. TD Asset Management Inc. owned about 1.51% of Encompass Health worth $140,641,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the business. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after buying an additional 137 shares in the last quarter. Avior Wealth Management LLC bought a new stake in Encompass Health in the 3rd quarter valued at $40,000. CBIZ Investment Advisory Services LLC lifted its stake in Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after purchasing an additional 127 shares in the last quarter. Tompkins Financial Corp bought a new position in shares of Encompass Health during the 4th quarter valued at about $46,000. Finally, V Square Quantitative Management LLC grew its position in shares of Encompass Health by 43.8% during the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after purchasing an additional 177 shares in the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Price Performance

Shares of EHC stock opened at $100.71 on Wednesday. The stock has a 50 day moving average price of $98.28 and a 200 day moving average price of $97.26. The firm has a market capitalization of $10.14 billion, a P/E ratio of 22.58, a P/E/G ratio of 2.31 and a beta of 0.92. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. Encompass Health Co. has a 52-week low of $76.11 and a 52-week high of $104.55.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, sell-side analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a yield of 0.68%. Encompass Health’s dividend payout ratio (DPR) is currently 15.25%.

Insiders Place Their Bets

In other news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. 2.10% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on EHC shares. William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. Barclays boosted their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, February 7th. KeyCorp lifted their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, Encompass Health has a consensus rating of “Buy” and a consensus target price of $107.67.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.